Literature DB >> 27822611

Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.

Shin Yeu Ong1, Yun Ann Chin1, Hein Than1, Chuen Wen Tan1, Eng Soo Yap2, Wan Hui Wong1, Heng Joo Ng3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27822611     DOI： 10.1007/s00277-016-2871-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

1.  Extensive Intracardiac and Deep Venous Thromboses in a Young Woman with Heparin-Induced Thrombocytopenia and May-Thurner Syndrome.

Authors:  Yekaterina Kim; Daniel C Choi; Ali N Zaidi
Journal:  Case Rep Hematol       Date:  2017-03-30

Review 2.  Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome.

Authors:  Julie Carré; Georges Jourdi; Nicolas Gendron; Dominique Helley; Pascale Gaussem; Luc Darnige
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

3.  Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience.

Authors:  Mohamed Aon; Omar Al-Shammari
Journal:  Case Rep Hematol       Date:  2020-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.